Ocutrx CEO Michael Freeman Honors a Promise to Develop AR Device That Could Help AMD Patients See

Twenty five years ago, Michael Freeman collaborated with his father and brothers to create the first video technology that could transmit via cellular technology. As important an achievement as that might be, Freeman is developing an augmented reality device that could have an even greater impact on people who have lost their vision to Macular Degeneration. Once again, Freeman and his brothers have their father’s leadership to thank.